Home » Topics » Drugs » Immuno-oncology

Immuno-oncology
RSS

Advanced Viral Research plans IND filing for injectable AVR-118

Sep. 13, 2004

HGS-ETR1 advanced into phase II

Sep. 13, 2004

Takara Bio and CAMS to codevelop cancer immunotherapies in China

Sep. 9, 2004

Positive interim results from phase II trials of TroVax

Sep. 3, 2004

Antitumor efficacy of ABX-EGF in metastatic renal cancer

Sep. 1, 2004

Aphton seeks Canadian registration of Insegia in pancreatic cancer

Aug. 30, 2004

SGN-40 receives orphan drug designation for multiple myeloma

Aug. 26, 2004

Medarex reaches SPA agreement for phase III trial of MDX-010

Aug. 26, 2004

Orphan drug status for HuMax-CD4

Aug. 24, 2004

Viragen updates Multiferon progress

Aug. 24, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
FENS 2026: Shedding light on the sheddome
BioWorld
At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...
FENS 2026: Next-gen biologics take on brain disease
BioWorld
Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...